Where does Akamis Bio Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Akamis Bio Limited ranks #34,150 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Akamis Bio Limited hold?

Akamis Bio Limited holds 7 US utility patents granted between 2023 and 2025, spanning 5 technology areas.

What is Akamis Bio Limited's Innovation Score?

Akamis Bio Limited has an Innovation Score of 45.7 out of 100 (top 22% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Akamis Bio Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Akamis Bio Limited.

What does claim depth mean for Akamis Bio Limited's patents?

Akamis Bio Limited's patents average 17.7 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Akamis Bio Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Akamis Bio Limited

Q: What technology areas does Akamis Bio Limited focus on?

Akamis Bio Limited's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 7 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Akamis ranks #34,150 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.

#34,150
of 49,997 US assignees by volume: Top 22%
by Innovation Score (45.7/100): 17.7
avg claims per patent

USPTO PatentsView assignee plate

Corpus R34150 · Foreign Corporation #34,150 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
MID-PACK #34,150/49,997
PHOTO-FINISH Aircam
CPC-NARROW A61K · 5 areas
INNOV-PAR 45.7/100
CLAIMS-RICH 17.7 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Aircam Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Akamis Bio · this assignee

46
3D Lighting… · lowest

7

What this shows Akamis's Innovation Score is 45.7/100 (top 22% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Akamis's grants concentrate

Akamis Bio Limited is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2024 (4 grants) versus a trough of 1 in 2023. By volume, Akamis sits between Aircam Inc. and Akoya LLC.

Akamis's three-year grant acceleration

Akamis Bio Limited shows 5 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Aircam

7
Airspace Systems

7
Airwall Hangers

7
Ajax Tocco Magnet…

7
Akash Systems

7
Akebono Brake

7
Aker Engineering…

7
Akoya

7
Akamis Bio ◀

7

What this shows Akamis holds 7 patents at rank #34,277, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Akamis

By rank, the assignees closest to #34,277 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Akamis's primary technology class.

Akamis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Akamis Bio Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	1	14.3%
2024	4	57.1%
2025partial year	2	28.6%

Which technologies does Akamis Bio Limited patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 7

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 6

C07K - Peptides 4

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#34,150

of 49,997 tracked assignees

Innovation Score

45.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Akamis Bio Limited's patent record in context - here's where to go next.

Akamis Bio Limited's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #34,150 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Akamis Bio Limited against Aircam Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 45.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.